Cognitive impairment associated with Atrial fibrillation: A meta-analysis

Annals of Internal Medicine

Volumn 158, Issue 5 PART 1, 2013, Pages 338-346

  Kalantarian, Shadi ^a   Stern, Theodore A ^b   Mansour, Moussa ^a   Ruskin, Jeremy N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Inpatient Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DEMENTIA; DISEASE ASSOCIATION; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLISHING; RECURRENT DISEASE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 84874715700     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-5-201303050-00007     Document Type: Review

References (55)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220. [PMID: 22179539]
2. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29:125-32. [PMID: 17975326]
3. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail. 2007;9:440-9. [PMID: 17174152]
4. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care. 2005;28:726-35. [PMID: 15735218]
5. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484-91. [PMID: 22372522]
6. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993;138:353-64. [PMID: 8213741]
7. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, et al; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001; 56:42-8. [PMID: 11148234]
8. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008;4:363-81. [PMID: 18561512]
9. Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord. 2001;15:169-73. [PMID: 11723367]
10. Alzheimer's Association. 2012 Alzheimer's disease facts and figures. Alzheimers Dement. 2012;8:131-68. [PMID: 22404854]
11. Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm. 2010;7:433-7. [PMID: 20122875]
12. Dublin S, Anderson ML, Haneuse SJ, Heckbert SR, Crane PK, Breitner JC, et al. Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc. 2011;59:1369-75. [PMID: 21806558]
13. Elias MF, Sullivan LM, Elias PK, Vasan RS, D'Agostino RB Sr, Seshadri S, et al. Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men. J Stroke Cerebrovasc Dis. 2006;15:214-22. [PMID: 17904078]
14. Marengoni A, Qiu C, Winblad B, Fratiglioni L. Atrial fibrillation, stroke and dementia in the very old: a population-based study. Neurobiol Aging. 2011; 32:1336-7. [PMID: 19732992]
15. Park H, Hildreth A, Thomson R, O'Connell J. Non-valvular atrial fibrillation and cognitive decline: a longitudinal cohort study. Age Ageing. 2007;36: 157-63. [PMID: 17259637]
16. Peters R, Poulter R, Beckett N, Forette F, Fagard R, Potter J, et al. Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial. J Hypertens. 2009;27:2055-62. [PMID: 19696686]
17. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-52. [PMID: 9737513]
18. Kwok CS, Loke YK, Hale R, Potter JF, Myint PK. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011; 76:914-22. [PMID: 21383328]
19. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12. [PMID: 10789670]
20. Thompson S, Ekelund U, Jebb S, Lindroos AK, Mander A, Sharp S, et al. A proposed method of bias adjustment for meta-analyses of published observational studies. Int J Epidemiol. 2011;40:765-77. [PMID: 21186183]
21. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol. 2005;161:280-8. [PMID: 15671260]
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition, revised. Washington, DC: American Psychiatric Assoc; 1987.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Assoc; 1994.
24. Centers for Disease Control and Prevention. Classifications of Diseases, Functioning, and Disability: International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Atlanta: Centers for Disease Control and Prevention. Accessed at www.cdc.gov/nchs/icd/icd9cm.htm on 19 November 2012.
25. Centers for Disease Control and Prevention. Classifications of Diseases, Functioning, and Disability: International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Atlanta, GA: Centers for Disease Control and Prevention. Accessed at www.cdc.gov/nchs/icd/icd10cm.htm on 19 November 2012.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. [PMID: 3802833]
27. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. Accessed at www.cochrane-handbook.org on 19 November 2012.
28. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 1997;28:316-21. [PMID: 9040682]
29. Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, et al. Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc. 1998;46:1343-8. [PMID: 9809754]
30. Jozwiak A, Guzik P, Mathew A, Wykretowicz A, Wysocki H. Association of atrial fibrillation and focal neurologic deficits with impaired cognitive function in hospitalized patients or 65 years of age. Am J Cardiol. 2006;98:1238-41. [PMID: 17056337]
31. Debette S, Bauters C, Leys D, Lamblin N, Pasquier F, de Groote P. Prevalence and determinants of cognitive impairment in chronic heart failure patients. Congest Heart Fail. 2007;13:205-8. [PMID: 17673872]
32. Bilato C, Corti MC, Baggio G, Rampazzo D, Cutolo A, Iliceto S, et al. Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study). Am J Cardiol. 2009;104:1092-7. [PMID: 19801031]
33. Tilvis RS, Kähönen-Väre MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59:268-74. [PMID: 15031312]
34. Forti P, Maioli F, Pisacane N, Rietti E, Montesi F, Ravaglia G. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI). Arch Gerontol Geriatr. 2007;44 (Suppl1):155-65. [PMID: 17317449]
35. Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al; Chongqing Ageing Study Group. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485-91. [PMID: 21490316]
36. Marzona I, O'Donnell M, Teo K, Gao P, Anderson C, Bosch J, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ. 2012;184: E329-36. [PMID: 22371515]
37. Inzitari D, Di Carlo A, Pracucci G, Lamassa M, Vanni P, Romanelli M, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke. 1998;29:2087-93. [PMID: 9756587]
38. Barba R, Martínez-Espinosa S, Rodríguez-García E, Pondal M, Vivancos J, Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke. 2000; 31:1494-501. [PMID: 10884443]
39. Altieri M, Di Piero V, Pasquini M, Gasparini M, Vanacore N, Vicenzini E, et al. Delayed poststroke dementia: a 4-year follow-up study. Neurology. 2004; 62:2193-7. [PMID: 15210881]
40. Zhou DH, Wang JY, Li J, Deng J, Gao C, Chen M. Study on frequency and predictors of dementia after ischemic stroke: the Chongqing stroke study. J Neurol. 2004;251:421-7. [PMID: 15083286]
41. Tang WK, Chan SS, Chiu HF, Ungvari GS, Wong KS, Kwok TC, et al. Frequency and clinical determinants of poststroke cognitive impairment in nondemented stroke patients. J Geriatr Psychiatry Neurol. 2006;19:65-71. [PMID: 16690990]
42. Mizrahi EH, Waitzman A, Arad M, Adunsky A. Atrial fibrillation predicts cognitive impairment in patients with ischemic stroke. Am J Alzheimers Dis Other Demen. 2011;26:623-6. [PMID: 22218734]
43. Khan M, Ahmed B, Ahmed M, Najeeb M, Raza E, Khan F, et al. Functional, cognitive and psychological outcomes, and recurrent vascular events in Pakistani stroke survivors: a cross sectional study. BMC Res Notes. 2012;5:89. [PMID: 22321339]
44. Barber M, Tait RC, Scott J, Rumley A, Lowe GD, Stott DJ. Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J Thromb Haemost. 2004;2:1873-8. [PMID: 15550013]
45. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation. 1995;92:2178-82. [PMID: 7554199]
46. Feinberg WM, Seeger JF, Carmody RF, Anderson DC, Hart RG, Pearce LA. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med. 1990;150:2340-4. [PMID: 2241443]
47. Farina E, Magni E, Ambrosini F, Manfredini R, Binda A, Sina C, et al. Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurol Scand. 1997;96:310-6. [PMID: 9405001]
48. Lavy S, Stern S, Melamed E, Cooper G, Keren A, Levy P. Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke. 1980;11:35-8. [PMID: 7355427]
49. Anderson JL, Allen Maycock CA, Lappé DL, Crandall BG, Horne BD, Bair TL, et al; Intermountain Heart Collaborative Study group. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol. 2004;94: 1255-9. [PMID: 15541240]
50. Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, et al. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently. Pacing Clin Electrophysiol. 2009;32:648-52. [PMID: 19422587]
51. de Leeuw FE, de Groot JC, Oudkerk M, Kors JA, Hofman A, van Gijn J, et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology. 2000;54:1795-801. [PMID: 10802786]
52. Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. Accessed at www.cochrane-handbook.org on 19 November 2012.
53. Teo K, Yusuf S, Sleight P, Anderson C, Mookadam F, Ramos B, et al; ONTARGET/TRANSCEND Investigators. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J. 2004;148:52-61. [PMID: 15215792]
54. Greenland S. Invited commentary: a critical look at some popular metaanalytic methods. Am J Epidemiol. 1994;140:290-6. [PMID: 8030632]
55. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282:1054-60. [PMID: 10493204]